Antisense inhibition of dual specific phosphatase 9 expression
AssigneeIsis Pharmaceuticals, Inc.
InventorsLex M. Cowsert, Brett P. Monia
Life of this patent
Estimating the term…
Abstract
Antisense compounds, compositions and methods are provided for modulating the expression of Dual specific phosphatase 9. The compositions comprise antisense compounds, particularly antisense oligonucleotides, targeted to nucleic acids encoding Dual specific phosphatase 9. Methods of using these compounds for modulation of Dual specific phosphatase 9 expression and for treatment of diseases associated with expression of Dual specific phosphatase 9 are provided.
Claims20
A compound 8 to 50 nucleobases in length targeted to a nucleic acid molecule encoding Dual specific phosphatase 9, wherein said compound specifically hybridizes with said nucleic acid molecule encoding Dual specific phosphatase 9 and inhibits the expression of Dual specific phosphatase 9.
A compound 8 to 50 nucleobases in length which specifically hybridizes with at least an 8-nucleobase portion of an active site on a nucleic acid molecule encoding Dual specific phosphatase 9.
Dependencies are inferred from the claim text.